Imunon, Inc.

NASDAQ (USD): Imunon, Inc. (IMNN)

Last Price

1.02

Today's Change

+0.02 (2.00%)

Day's Change

0.97 - 1.03

Trading Volume

1,273,863

Overview

Market Cap

17 Million

Shares Outstanding

17 Million

Avg Volume

11,230,912

Avg Price (50 Days)

1.09

Avg Price (200 Days)

0.97

PE Ratio

-0.74

EPS

-1.38

Earnings Announcement

12-Aug-2025

Previous Close

1.00

Open

1.00

Day's Range

0.97 - 1.03

Year Range

0.37 - 3.65

Trading Volume

1,273,863

Price Change Highlight

1 Day Change

2.00%

5 Day Change

-23.31%

1 Month Change

155.51%

3 Month Change

7.37%

6 Month Change

22.89%

Ytd Change

-2.86%

1 Year Change

-8.93%

3 Year Change

-46.88%

5 Year Change

-98.38%

10 Year Change

-99.80%

Max Change

-99.99%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Imunon, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of DNA-based immunotherapies, vaccines, and directed chemotherapies. Its product pipeline includes GEN-1, a DNA-based immunotherapy for the localized treatment of ovarian cancer; and ThermoDox, a proprietary heat-activated liposomal encapsulation of doxorubicin, which is in development stage for various cancer indications. The company also has two feasibility stage platform technologies for the development of nucleic acid-based immunotherapies, vaccines, and other anti-cancer DNA or RNA therapies. The company was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. Imunon, Inc. was founded in 1982 and is based in Lawrenceville, New Jersey.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment